These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30772011)

  • 1. The inhibitory subunit of cardiac troponin (cTnI) is modified by arginine methylation in the human heart.
    Onwuli DO; Samuel SF; Sfyri P; Welham K; Goddard M; Abu-Omar Y; Loubani M; Rivero F; Matsakas A; Benoit DM; Wade M; Greenman J; Beltran-Alvarez P
    Int J Cardiol; 2019 May; 282():76-80. PubMed ID: 30772011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
    Lindhout DA; Li MX; Schieve D; Sykes BD
    Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
    Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
    Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.
    Schmidtmann A; Lindow C; Villard S; Heuser A; Mügge A; Gessner R; Granier C; Jaquet K
    FEBS J; 2005 Dec; 272(23):6087-97. PubMed ID: 16302972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development.
    Gomes AV; Liang J; Potter JD
    J Biol Chem; 2005 Sep; 280(35):30909-15. PubMed ID: 15961398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1.
    You B; Yan G; Zhang Z; Yan L; Li J; Ge Q; Jin JP; Sun J
    Biochem J; 2009 Feb; 418(1):93-101. PubMed ID: 18986304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene.
    Gomes AV; Potter JD
    Mol Cell Biochem; 2004 Aug; 263(1-2):99-114. PubMed ID: 15524171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca(2+) induces an extended conformation of the inhibitory region of troponin I in cardiac muscle troponin.
    Dong WJ; Xing J; Robinson JM; Cheung HC
    J Mol Biol; 2001 Nov; 314(1):51-61. PubMed ID: 11724531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.
    Barta J; Tóth A; Jaquet K; Redlich A; Edes I; Papp Z
    Mol Cell Biochem; 2003 Sep; 251(1-2):83-8. PubMed ID: 14575308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.
    Ayaz-Guner S; Zhang J; Li L; Walker JW; Ge Y
    Biochemistry; 2009 Sep; 48(34):8161-70. PubMed ID: 19637843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of the δPKC interaction with the d subunit of F1Fo ATP synthase reduces cardiac troponin I release from ischemic rat hearts: utility of a novel ammonium sulfate precipitation technique.
    Ogbi M; Obi I; Johnson JA
    PLoS One; 2013; 8(8):e70580. PubMed ID: 23936451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation.
    Rarick HM; Tang HP; Guo XD; Martin AF; Solaro RJ
    J Mol Cell Cardiol; 1999 Feb; 31(2):363-75. PubMed ID: 10093049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
    Wang YS; Zhou J; Hong K; Cheng XS; Li YG
    Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pim-1 Kinase Phosphorylates Cardiac Troponin I and Regulates Cardiac Myofilament Function.
    Zhu N; Yi B; Guo Z; Zhang G; Huang S; Qin Y; Zhao X; Sun J
    Cell Physiol Biochem; 2018; 45(6):2174-2186. PubMed ID: 29544221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry.
    Zabrouskov V; Ge Y; Schwartz J; Walker JW
    Mol Cell Proteomics; 2008 Oct; 7(10):1838-49. PubMed ID: 18445579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding.
    Köhler J; Chen Y; Brenner B; Gordon AM; Kraft T; Martyn DA; Regnier M; Rivera AJ; Wang CK; Chase PB
    Physiol Genomics; 2003 Jul; 14(2):117-28. PubMed ID: 12759477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis.
    Kaya Z; Göser S; Buss SJ; Leuschner F; Ottl R; Li J; Völkers M; Zittrich S; Pfitzer G; Rose NR; Katus HA
    Circulation; 2008 Nov; 118(20):2063-72. PubMed ID: 18955666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.